Femoral Artery Complications Associated with the Mynx Closure Device

Liu, K. C.; Lee, D. S.; Gonda, S.J.; Doğan, Ahmet; Gultekin, Sakir H.; Nesbit, Gary M.; Petersen, Bryan D.; Barnwell, Stanley L.

doi:10.3174/ajnr.a2153

Cited by 32 publications

(22 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Closure with the Mynx device leads to enhanced patient comfort, rapid haemostasis, reduced time to ambulation, and hospital stay [8,9]. Published results with Mynx are variable with some studies reporting it is safe and effective and others reporting less favourable complication rates mainly in the early stages of deployment and especially associated with a new operator's learning curve [7][8][9][10]. Our study found that the Mynx was indeed an effective closure device (98.9% successful deployment).…”

Section: Discussionmentioning

confidence: 57%

Single-centre real world experience of the Mynx Femoral closure device in patients undergoing percutaneous coronary intervention

Thirunavukarasu¹,

Zaman²,

Hayat³

et al. 2019

J Cardiol Cardiovasc Med

View full text Add to dashboard Cite

Background: Vascular closure devices are routinely used following femoral artery access to perform percutaneous coronary interventions (PCI). A number of devices are available on the market. We have reported previously on our experience of the Mynx device following diagnostic coronary angiography. Aims: To assess the success and complication rates of the Mynx device used in all-comers in the context of PCI within a single cardiac centre. Methods: Retrospective analysis of data available for patients who underwent PCI via the femoral route and received a Mynx device at a single tertiary centre. Results: The device was used to achieve haemostasis in 113 patients following PCI. In all cases weight-adjusted Heparin as well as dual antiplatelet therapy (Aspirin and Clopidogrel/ Ticagrelor) was administered as per PCI protocol. The device was successfully deployed in 111 cases (98.2%). The were 2 cases of device failure, one due to operator error and the other due to Mynx grip balloon bursting during device deployment. In 15 cases (13.2%; 9 male and 6 female) there were reports of small haematomas (<2cm) or oozing resulting in application of manual pressure or Femstop (St. Jude). A further patient required ultrasound-guided compression of the artery due to a large retroperitoneal bleed resulting from access complications. A larger proportion of the cases with complications were done as PPCI (44% vs 33%). The group with complications had higher systolic BP (140mmHg vs 128mmHg; P<0.05) and MABP (97mmHg vs 75mmHg; P<0.05) as compared with the group without any complications. Conclusion: The Mynx closure device is safe and easy to use in the context of PCI, in both the elective and emergency (PPCI) settings. Complication rates, predominately minor, can be minimised in experienced hands. Single-centre real world experience of the Mynx Femoral closure device in patients undergoing percutaneous coronary intervention

show abstract

Section: Discussionmentioning

confidence: 57%

Single-centre real world experience of the Mynx Femoral closure device in patients undergoing percutaneous coronary intervention

Thirunavukarasu¹,

Zaman²,

Hayat³

et al. 2019

J Cardiol Cardiovasc Med

View full text Add to dashboard Cite

show abstract

“…A recent review by Fields et al 47 underscores this concept, as the authors found that among patients with follow-up femoral angiographic studies after having undergone previous arteriotomy closure with the Mynx device, 18% had intravascular sealant and 11% had pseudoaneuryms. With the exception of one patient, all were asymptomatic.…”

Section: Discussionmentioning

confidence: 99%

Safety and efficacy of percutaneous femoral artery access followed by Mynx closure in cerebral neurovascular procedures: a single center analysis

Grandhi

Kanaan

Shah

et al. 2013

J NeuroIntervent Surg

View full text Add to dashboard Cite

show abstract

“…Recently, Fields and colleagues observed an 18% incidence of intravascular Mynx sealant and 11% rate of pseudoaneurysm formation among 26 patients who underwent follow-up femoral artery angiography at a mean time point of 6 days following initial arterial closure 2. One patient with intravascular sealant underwent surgical exploration for near occlusion of the ipsilateral superficial femoral artery.…”

Section: Discussionmentioning

confidence: 99%

Occurrence of angiographic femoral artery complications after vascular closure with Mynx and AngioSeal

Fargen

Velat

Lawson

et al. 2012

J NeuroIntervent Surg

View full text Add to dashboard Cite

show abstract

Femoral Artery Complications Associated with the Mynx Closure Device

Cited by 32 publications

References 3 publications

Single-centre real world experience of the Mynx Femoral closure device in patients undergoing percutaneous coronary intervention

Single-centre real world experience of the Mynx Femoral closure device in patients undergoing percutaneous coronary intervention

Safety and efficacy of percutaneous femoral artery access followed by Mynx closure in cerebral neurovascular procedures: a single center analysis

Occurrence of angiographic femoral artery complications after vascular closure with Mynx and AngioSeal

Contact Info

Product

Resources

About